144 related articles for article (PubMed ID: 9334381)
1. Suppression of leukotriene B4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils.
Krump E; Picard S; Mancini J; Borgeat P
J Exp Med; 1997 Oct; 186(8):1401-6. PubMed ID: 9334381
[TBL] [Abstract][Full Text] [Related]
2. Adenosine. An endogenous inhibitor of arachidonic acid release and leukotriene biosynthesis in human neutrophils.
Krump E; Borgeat P
Adv Exp Med Biol; 1999; 447():107-15. PubMed ID: 10086187
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of leukotriene biosynthesis by human granulocytes in presence of plasma.
Palmantier R; Rocheleau H; Laviolette M; Mancini J; Borgeat P
Biochim Biophys Acta; 1998 Jan; 1389(3):187-96. PubMed ID: 9512647
[TBL] [Abstract][Full Text] [Related]
4. Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: inhibition by adenosine A(2a) receptor agonists and crucial role of autocrine activation by leukotriene B(4).
Surette ME; Krump E; Picard S; Borgeat P
Mol Pharmacol; 1999 Nov; 56(5):1055-62. PubMed ID: 10531413
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of leukotriene B4 export from human polymorphonuclear leukocytes.
Lam BK; Gagnon L; Austen KF; Soberman RJ
J Biol Chem; 1990 Aug; 265(23):13438-41. PubMed ID: 2166027
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A2 receptor-induced inhibition of leukotriene B4 synthesis in whole blood ex vivo.
Krump E; Lemay G; Borgeat P
Br J Pharmacol; 1996 Apr; 117(8):1639-44. PubMed ID: 8732271
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibitory effects of auranofin on leukotriene B4 and leukotriene C4 formation by human polymorphonuclear leukocytes.
Honda Z; Iizasa T; Morita Y; Matsuta K; Nishida Y; Miyamoto T
Biochem Pharmacol; 1987 May; 36(9):1475-81. PubMed ID: 3034290
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene A4 modulates generation of leukotriene B4 and sulphidopeptide leukotrienes by human neutrophils.
Hilger RA; König W
Immunology; 1992 Nov; 77(3):408-15. PubMed ID: 1335961
[TBL] [Abstract][Full Text] [Related]
9. Captopril inhibits neutrophil synthesis of leukotriene B4 in vitro and in vivo.
Shindo K; Baker JR; Munafo DA; Bigby TD
J Immunol; 1994 Dec; 153(12):5750-9. PubMed ID: 7989772
[TBL] [Abstract][Full Text] [Related]
10. Oxygen free radicals are required for ischemia-induced leukotriene B4 synthesis and diapedesis.
Goldman G; Welbourn R; Klausner JM; Valeri CR; Shepro D; Hechtman HB
Surgery; 1992 Mar; 111(3):287-93. PubMed ID: 1311874
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene B4 formation: human neutrophil-airway epithelial cell interactions.
Zhou S; Stark JM; Leikauf GD
J Appl Physiol (1985); 1995 Apr; 78(4):1396-403. PubMed ID: 7615447
[TBL] [Abstract][Full Text] [Related]
12. Acetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis and cyclic AMP accumulation in human polymorphonuclear leukocytes.
Gorman RR; Morton DR; Hopkins NK; Lin AH
Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():57-63. PubMed ID: 6303092
[TBL] [Abstract][Full Text] [Related]
13. The leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites.
Haines KA; Giedd KN; Rich AM; Korchak HM; Weissmann G
Biochem J; 1987 Jan; 241(1):55-62. PubMed ID: 3032161
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human neutrophil leukotriene B4 synthesis in essential fatty acid deficiency: role of leukotriene A hydrolase.
Cleland LG; James MJ; Proudman SM; Neumann MA; Gibson RA
Lipids; 1994 Mar; 29(3):151-5. PubMed ID: 8170283
[TBL] [Abstract][Full Text] [Related]
15. Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice.
Byrum RS; Goulet JL; Snouwaert JN; Griffiths RJ; Koller BH
J Immunol; 1999 Dec; 163(12):6810-9. PubMed ID: 10586081
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T
Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of leukotriene B4 by activated human polymorphonuclear granulocytes.
Brom J; Schönfeld W; König W
Immunology; 1988 Jul; 64(3):509-18. PubMed ID: 2842254
[TBL] [Abstract][Full Text] [Related]
18. Lipoxygenase product formation and cell adhesion during neutrophil-glomerular endothelial cell interaction.
Brady HR; Lamas S; Papayianni A; Takata S; Matsubara M; Marsden PA
Am J Physiol; 1995 Jan; 268(1 Pt 2):F1-12. PubMed ID: 7840235
[TBL] [Abstract][Full Text] [Related]
19. Effects of metalloproteinase inhibitors on leukotriene A4 hydrolase in human airway epithelial cells.
Baker JR; Kylstra TA; Bigby TD
Biochem Pharmacol; 1995 Sep; 50(7):905-12. PubMed ID: 7575672
[TBL] [Abstract][Full Text] [Related]
20. Potent and selective inhibitors of leukotriene A4 hydrolase: effects on purified enzyme and human polymorphonuclear leukocytes.
Wetterholm A; Haeggström JZ; Samuelsson B; Yuan W; Munoz B; Wong CH
J Pharmacol Exp Ther; 1995 Oct; 275(1):31-7. PubMed ID: 7562564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
